Selenocysteine tRNA methylation promotes oxidative stress resistance in melanoma metastasis

Leona A. Nease,Kellsey P. Church,Ines Delclaux,Shino Murakami,Maider Astorkia,Marwa Zerhouni,Graciela Cascio,Riley O. Hughes,Kelsey N. Aguirre,Paul Zumbo,Lukas E. Dow,Samie Jaffrey,Doron Betel,Elena Piskounova
DOI: https://doi.org/10.1101/2023.10.02.560568
2024-09-10
Abstract:Selenocysteine-containing proteins play a central role in redox homeostasis. Their translation is a highly regulated process, dependent upon two tRNA isodecoders differing by a single 2’-O-ribose methylation, called Um34. We characterized FTSJ1 as the Um34 methyltransferase and show that its activity is required for efficient selenocysteine insertion at the UGA stop codon during translation. Specifically, Loss of Um34 leads to ribosomal stalling and decreased UGA recoding. FTSJ1-deficient cells are more sensitive to oxidative stress and have decreased metastatic colonization in xenograft models of melanoma metastasis. We found that FTSJ1 mediates efficient translation of selenoproteins essential for the cellular antioxidant response. Our findings uncover a role for tRNA Um34 modification in oxidative stress resistance and highlight FTSJ1 as a potential therapeutic target specific for metastatic disease.
Cancer Biology
What problem does this paper attempt to address?